Bupropion-Mepha XR 300 mg, Retardtabletten - 30 Swissmedic Key 69313002 Registration Holder Mepha Pharma AG Name Bupropion-Mepha XR 300 mg, Retardtabletten Date of registration 25.10.2024 Introduction of Sequence 25.10.2024 ATC-Classification Bupropion (N06AX12) Revision date WHO WHO-DDD Valid until 24.10.2029 Index Therapeuticus (BSV) Show package size 30 Index Therapeuticus (Swissmedic) 01.06. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680693130029 Medication Code Synthetika Pharmacode Disponibility
Composition bupropioni hydrochloridum 300 mg, povidonum K 90, cysteini hydrochloridum monohydricum, silica colloidalis anhydrica, glyceroli dibehenas, magnesii stearas, Überzug: ethylcellulosum, povidonum K 90, macrogolum 1450, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, polysorbatum 80, natrii laurilsulfas corresp. natrium 0.005 mg, silica colloidalis hydrica, triethylis citras, Drucktinte corresp.: lacca, E 172 (nigrum), pro compresso obducto. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Bupropion Hydrochloride 300 mg
Inactive agents Dose additional_information (Nigrum) Acidi Methacrylici Cystein Hydrochloride Monohydrate E 172 color. Ethylcellulosum Überzug Ethylis Acrylatis Polymerisatum Glyceroli Dibehenas Lacca Drucktinte corresp. Macrogol 1450 Magnesii Stearas Natrii Laurilsulfas Polysorbatum 80 Povidonum K 90 Pro Compresso Obducto Silica Colloidalis Anhydrica Silica Colloidalis Hydrica Triethylis Citras
Source Data was imported : 06.11.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
